Delayed deviation closures and lagging CAPA resolution slow batch disposition, escalate regulatory risk and drain operational resources across life sciences sites. Weak root cause investigations, inconsistent documentation and workflow silos intensify recurring issues, costing teams valuable production time and revenue. Organizations need structured deviation systems, robust trending and proactive gap closure to unblock product release while sustaining compliance.